Learn more

INDIVUMED GMBH

Overview
  • Total Patents
    48
  • GoodIP Patent Rank
    213,362
About

INDIVUMED GMBH has a total of 48 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are MERCEY THIBAUT, SHANDONG BINZHOU ANIMAL SCIENCE & VETERINARY MEDICINE ACADEMY and CD DIAGNOSTICS INC.

Patent filings per year

Chart showing INDIVUMED GMBHs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Juhl Hartmut 36
#2 David Kerstin 28
#3 Fentz Anne-Kristin 14
#4 Kerstin David 4
#5 Hartmut Juhl 4
#6 Unger Florian T 3
#7 Fentz Anne Kristin 2
#8 Anne-Kristin Fentz 2
#9 Anne-Kristin Juhl Hartmut Davi 1
#10 David Kerstin Dr 1

Latest patents

Publication Filing date Title
EP3175243A2 Methods for assessing biological sample quality
ZA200801353B Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma ; method for detection and test system
WO2007065463A1 USE OF C3a AND DERIVATIVES THEREOF AS A BIOMARKER FOR BENIGN LUNG TISSUE ALTERATIONS AND MALIGN LUNG TUMORS, METHOD FOR DETECTION AND TEST SYSTEM
ZA200801176B Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma ; method for detection and test system
CN101238373A Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
BRPI0520483A2 method for detecting colorectal adenoma and / or colorectal carcinoma, method for discriminating between colorectal adenoma and colorectal carcinoma or additional tumor states, method for monitoring development and / or course and / or treatment of colorectal adenoma and / or colorectal carcinoma Discrimination Between Different Tumor Stages, Endoplasmin Fragment Use, Test System, Arrangement, Method for Determining Whether a Compound Is Effective in Treating Colorectal Adenoma and / or Colorectal Carcinoma, and / or Tumor Specific Stages
BRPI0514314A method for detecting and discriminating between colorectal adenoma and / or colorectal carcinoma, method for monitoring development and / or course and / or treatment of colorectal adenoma and / or colorectal carcinoma, use of c3a or derivative thereof, test system, kit comprising molecules, method for determining whether a compound is effective in the treatment of colorectal adenoma and / or colorectal carcinoma
KR20070051327A Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
CN101014859A Use of transthyretin as a biomarker for colorectal adenoma and/or cancer, method for detection and test system
ZA200701187B Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma ; method for detection and test system
WO2005064308A1 Apparatus for working up a solid biological specimen
DE10261529A1 Procedure for creating a collection of biological sample material and sample collection
EP1259263A1 Complexation of rna, especially ribozymes, with polyethylenimines for the stabilization and cellular introduction thereof